sennoside a&b has been researched along with Multiple Myeloma in 1 studies
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugita, K | 1 |
| Nishio, D | 1 |
| Kabashima, K | 1 |
| Tokura, Y | 1 |
1 other study available for sennoside a&b and Multiple Myeloma
| Article | Year |
|---|---|
Acute generalized exanthematous pustulosis caused by sennoside in a patient with multiple myeloma.
Topics: Aged; Anthraquinones; Cathartics; Drug Eruptions; Exanthema; Female; Humans; Multiple Myeloma; Senna | 2008 |